A reverse- phase protein microarray-based screen identifies host signaling dynamics upon Burkholderia spp. infection

Frontiers in Microbiology

Volumn 6, Issue JUN, 2015, Pages

  Chiang, Chih Yuan ^a   Uzoma, Ijeoma ^a   Lane, Douglas J ^a   Memišević, Vesna ^b   Alem, Farhang ^c   Yao, Kuan ^c   Kota, Krishna P ^d   Bavari, Sina ^a   Wallqvist, Anders ^b   Hakami, Ramin M ^c   Panchal, Rekha G ^a  

^a UNITED STATES ARMY MEDICAL RESEARCH INSTITUTE OF INFECTIOUS DISEASES   (United States)

^b U S ARMY MEDICAL RESEARCH AND MATERIEL COMMAND   (United States)

^c GEORGE MASON UNIVERSITY   (United States)

^d PERKINELMER INC   (United States)

Author keywords

Burkholderia mallei; Burkholderia pseudomallei; Lipopolysaccharide; Reverse phase protein microarrays

Indexed keywords

ADENYLATE KINASE; BETA INTERFERON; INDUCIBLE NITRIC OXIDE SYNTHASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; NITRITE; STAT1 PROTEIN; BETA1A INTERFERON; MITOGEN ACTIVATED PROTEIN KINASE; MYC PROTEIN;

ANIMAL CELL; ARTICLE; BACTERIAL STRAIN; BURKHOLDERIA INFECTION; BURKHOLDERIA MALLEI; BURKHOLDERIA PSEUDOMALLEI; BURKHOLDERIA THAILANDENSIS; COLONY FORMING UNIT; CONTROLLED STUDY; DENSITOMETRY; ENZYME LINKED IMMUNOSORBENT ASSAY; IMMUNOBLOTTING; IMMUNOFLUORESCENCE TEST; IMMUNOHISTOCHEMISTRY; MACROPHAGE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN MICROARRAY; PROTEIN PHOSPHORYLATION; REVERSE PHASE PROTEIN MICROARRAY; SIGNAL TRANSDUCTION; DOWN REGULATION; GENE SEQUENCE; IMMUNE RESPONSE; IMMUNOFLUORESCENCE; INFLAMMATION; MOUSE; OPTICAL DENSITY; PHOSPHORYLATION;

BOS; BURKHOLDERIA; BURKHOLDERIA MALLEI; BURKHOLDERIA PSEUDOMALLEI; NEGIBACTERIA;

EID: 84936991882     PISSN: None     EISSN: 1664302X     Source Type: Journal    
DOI: 10.3389/fmicb.2015.00683     Document Type: Article

References (51)

1. Akira, S., Uematsu, S., and Takeuchi, O. (2006). Pathogen recognition and innate immunity. Cell 124, 783-801.
2. Alam, S., Amemiya, K., Bernhards, R.C., Ulrich, R.G., Waag, D.M., and Saikh, K.U. (2014). Characterization of cellular immune response and innate immune signaling in human and nonhuman primate primary mononuclear cells exposed to Burkholderia mallei. Microb Pathog 78C, 20-28.
3. Alem, F., Yao, K., Lane, D., Calvert, V., Petricoin, E.F., Kramer, L., Hale, M.L., Bavari, S., Panchal, R.G., and Hakami, R.M. (2015). Host response during Yersinia pestis infection of human bronchial epithelial cells involves negative regulation of autophagy and suggests a modulation of survival-related and cellular growth pathways. Front Microbiol 6, 50.
4. Anderson, T., Wulfkuhle, J., Liotta, L., Winslow, R.L., and Petricoin, E., 3rd (2009). Improved reproducibility of reverse-phase protein microarrays using array microenvironment normalization. Proteomics 9, 5562-5566.
5. Bast, A., Schmidt, I.H., Brauner, P., Brix, B., Breitbach, K., and Steinmetz, I. (2011). Defense Mechanisms of Hepatocytes Against Burkholderia pseudomallei. Front Microbiol 2, 277.
6. Brett, P.J., Burtnick, M.N., Su, H., Nair, V., and Gherardini, F.C. (2008). iNOS activity is critical for the clearance of Burkholderia mallei from infected RAW 264.7 murine macrophages. Cell Microbiol 10, 487-498.
7. Burtnick, M.N., Brett, P.J., and Woods, D.E. (2002). Molecular and physical characterization of Burkholderia mallei O antigens. J Bacteriol 184, 849-852.
8. Carling, D., Mayer, F.V., Sanders, M.J., and Gamblin, S.J. (2011). AMP-activated protein kinase: nature's energy sensor. Nat Chem Biol 7, 512-518.
9. Chantratita, N., Tandhavanant, S., Myers, N.D., Seal, S., Arayawichanont, A., Kliangsa-Ad, A., Hittle, L.E., Ernst, R.K., Emond, M.J., Wurfel, M.M., Day, N.P., Peacock, S.J., and West, T.E. (2013). Survey of innate immune responses to Burkholderia pseudomallei in human blood identifies a central role for lipopolysaccharide. PLoS One 8, e81617.
10. Coleman, J.W. (2001). Nitric oxide in immunity and inflammation. Int Immunopharmacol 1, 1397-1406.
11. D'elia, R.V., Harrison, K., Oyston, P.C., Lukaszewski, R.A., and Clark, G.C. (2013). Targeting the "cytokine storm" for therapeutic benefit. Clin Vaccine Immunol 20, 319-327.
12. Dance, D.A. (1991). Melioidosis: the tip of the iceberg? Clin Microbiol Rev 4, 52-60.
13. Dance, D.A. (2000). Ecology of Burkholderia pseudomallei and the interactions between environmental Burkholderia spp. and human-animal hosts. Acta Trop 74, 159-168.
14. De Keulenaer, B.L., and Cheng, A.C. (2006). Severe sepsis due to melioidosis. Chest 130, 1282.
15. Dharakul, T., and Songsivilai, S. (1999). The many facets of melioidosis. Trends Microbiol 7, 138-140.
16. Estes, D.M., Dow, S.W., Schweizer, H.P., and Torres, A.G. (2010). Present and future therapeutic strategies for melioidosis and glanders. Expert Rev Anti Infect Ther 8, 325-338.
17. Federici, G., Gao, X., Slawek, J., Arodz, T., Shitaye, A., Wulfkuhle, J.D., De Maria, R., Liotta, L.A., and Petricoin, E.F., 3rd (2013). Systems analysis of the NCI-60 cancer cell lines by alignment of protein pathway activation modules with "-OMIC" data fields and therapeutic response signatures. Mol Cancer Res 11, 676-685.
18. Galyov, E.E., Brett, P.J., and Deshazer, D. (2010). Molecular insights into Burkholderia pseudomallei and Burkholderia mallei pathogenesis. Annu Rev Microbiol 64, 495-517.
19. Gao, J.J., Filla, M.B., Fultz, M.J., Vogel, S.N., Russell, S.W., and Murphy, W.J. (1998). Autocrine/paracrine IFN-alphabeta mediates the lipopolysaccharide-induced activation of transcription factor Stat1alpha in mouse macrophages: pivotal role of Stat1alpha in induction of the inducible nitric oxide synthase gene. J Immunol 161, 4803-4810.
20. Gilad, J. (2007). Burkholderia mallei and Burkholderia pseudomallei: the causative micro organisms of glanders and melioidosis. Recent Pat Antiinfect Drug Discov 2, 233-241.
21. Han, C., Jin, J., Xu, S., Liu, H., Li, N., and Cao, X. (2010). Integrin CD11b negatively regulates TLR-triggered inflammatory responses by activating Syk and promoting degradation of MyD88 and TRIF via Cbl-b. Nat Immunol 11, 734-742.
22. Hii, C.S., Sun, G.W., Goh, J.W., Lu, J., Stevens, M.P., and Gan, Y.H. (2008). Interleukin-8 induction by Burkholderia pseudomallei can occur without Toll-like receptor signaling but requires a functional type III secretion system. J Infect Dis 197, 1537-1547.
23. Holden, M.T., Titball, R.W., Peacock, S.J., Cerdeno-Tarraga, A.M., Atkins, T., Crossman, L.C., Pitt, T., Churcher, C., Mungall, K., Bentley, S.D., Sebaihia, M., Thomson, N.R., Bason, N., Beacham, I.R., Brooks, K., Brown, K.A., Brown, N.F., Challis, G.L., Cherevach, I., Chillingworth, T., Cronin, A., Crossett, B., Davis, P., Deshazer, D., Feltwell, T., Fraser, A., Hance, Z., Hauser, H., Holroyd, S., Jagels, K., Keith, K.E., Maddison, M., Moule, S., Price, C., Quail, M.A., Rabbinowitsch, E., Rutherford, K., Sanders, M., Simmonds, M., Songsivilai, S., Stevens, K., Tumapa, S., Vesaratchavest, M., Whitehead, S., Yeats, C., Barrell, B.G., Oyston, P.C., and Parkhill, J. (2004). Genomic plasticity of the causative agent of melioidosis, Burkholderia pseudomallei. Proc Natl Acad Sci U S A 101, 14240-14245.
24. Improta, G., Zupa, A., Fillmore, H., Deng, J., Aieta, M., Musto, P., Liotta, L.A., Broaddus, W., Petricoin, E.F., 3rd, and Wulfkuhle, J.D. (2011). Protein pathway activation mapping of brain metastasis from lung and breast cancers reveals organ type specific drug target activation. J Proteome Res 10, 3089-3097.
25. Jacobs, A.T., and Ignarro, L.J. (2001). Lipopolysaccharide-induced expression of interferon beta mediates the timing of inducible nitric-oxide synthase induction in RAW 264.7 macrophages. J Biol Chem 276, 47950-47957.
26. Krachler, A.M., Woolery, A.R., and Orth, K. (2011). Manipulation of kinase signaling by bacterial pathogens. J Cell Biol 195, 1083-1092.
27. Leelarasamee, A. (2004). Recent development in melioidosis. Curr Opin Infect Dis 17, 131-136.
28. Martin, M., Rehani, K., Jope, R.S., and Michalek, S.M. (2005). Toll-like receptor-mediated cytokine production is differentially regulated by glycogen synthase kinase 3. Nat Immunol 6, 777-784.
29. Matsuzawa, A., Saegusa, K., Noguchi, T., Sadamitsu, C., Nishitoh, H., Nagai, S., Koyasu, S., Matsumoto, K., Takeda, K., and Ichijo, H. (2005). ROS-dependent activation of the TRAF6-ASK1-p38 pathway is selectively required for TLR4-mediated innate immunity. Nat Immunol 6, 587-592.
30. Molero, C., Rodriguez-Escudero, I., Aleman, A., Rotger, R., Molina, M., and Cid, V.J. (2009). Addressing the effects of Salmonella internalization in host cell signaling on a reverse-phase protein array. Proteomics 9, 3652-3665.
31. Pegoraro, G., Eaton, B.P., Ulrich, R.L., Lane, D.J., Ojeda, J.F., Bavari, S., Deshazer, D., and Panchal, R.G. (2014). A high-content imaging assay for the quantification of the Burkholderia pseudomallei induced multinucleated giant cell (MNGC) phenotype in murine macrophages. BMC Microbiol 14, 98.
32. Pilatz, S., Breitbach, K., Hein, N., Fehlhaber, B., Schulze, J., Brenneke, B., Eberl, L., and Steinmetz, I. (2006). Identification of Burkholderia pseudomallei genes required for the intracellular life cycle and in vivo virulence. Infect Immun 74, 3576-3586.
33. Popova, T.G., Turell, M.J., Espina, V., Kehn-Hall, K., Kidd, J., Narayanan, A., Liotta, L., Petricoin, E.F., 3rd, Kashanchi, F., Bailey, C., and Popov, S.G. (2010). Reverse-phase phosphoproteome analysis of signaling pathways induced by Rift valley fever virus in human small airway epithelial cells. PLoS ONE 5, e13805.
34. Propst, K.L., Troyer, R.M., Kellihan, L.M., Schweizer, H.P., and Dow, S.W. (2010).Immunotherapy markedly increases the effectiveness of antimicrobial therapy for. treatment of Burkholderia pseudomallei infection. Antimicrob Agents Chemother 54, 1785-1792.
35. Sasaki, C.Y., Barberi, T.J., Ghosh, P., and Longo, D.L. (2005). Phosphorylation of RelA/p65 on serine 536 defines an I{kappa}B{alpha}-independent NF-{kappa}B pathway. J Biol Chem 280, 34538-34547.
36. Sheehan, K.M., Calvert, V.S., Kay, E.W., Lu, Y., Fishman, D., Espina, V., Aquino, J., Speer, R., Araujo, R., Mills, G.B., Liotta, L.A., Petricoin, E.F., 3rd, and Wulfkuhle, J.D. (2005). Use of reverse phase protein microarrays and reference standard development for molecular network analysis of metastatic ovarian carcinoma. Mol Cell Proteomics 4, 346-355.
37. Steinbrecher, K.A., Wilson, W., 3rd, Cogswell, P.C., and Baldwin, A.S. (2005). Glycogen synthase kinase 3beta functions to specify gene-specific, NF-kappaB-dependent transcription. Mol Cell Biol 25, 8444-8455.
38. Tay, T.F., Maheran, M., Too, S.L., Hasidah, M.S., Ismail, G., and Embi, N. (2012). Glycogen synthase kinase-3beta inhibition improved survivability of mice infected with Burkholderia pseudomallei. Trop Biomed 29, 551-567.
39. Taylor, B.S., and Geller, D.A. (2000). Molecular regulation of the human inducible nitric oxide synthase (iNOS) gene. Shock 13, 413-424.
40. Thanos, D., and Maniatis, T. (1995). NF-kappa B: a lesson in family values. Cell 80, 529-532.
41. Thomas, K.E., Galligan, C.L., Newman, R.D., Fish, E.N., and Vogel, S.N. (2006). Contribution of interferon-beta to the murine macrophage response to the toll-like receptor 4 agonist, lipopolysaccharide. J Biol Chem 281, 31119-31130.
42. Ulett, G.C., Ketheesan, N., and Hirst, R.G. (2000). Cytokine gene expression in innately susceptible BALB/c mice and relatively resistant C57BL/6 mice during infection with virulent Burkholderia pseudomallei. Infect Immun 68, 2034-2042.
43. Utaisincharoen, P., Anuntagool, N., Arjcharoen, S., Limposuwan, K., Chaisuriya, P., and Sirisinha, S. (2004). Induction of iNOS expression and antimicrobial activity by interferon (IFN)-beta is distinct from IFN-gamma in Burkholderia pseudomallei infected mouse macrophages. Clin Exp Immunol 136, 277-283.
44. Utaisincharoen, P., Anuntagool, N., Limposuwan, K., Chaisuriya, P., and Sirisinha, S. (2003). Involvement of beta interferon in enhancing inducible nitric oxide synthase production and antimicrobial activity of Burkholderia pseudomallei-infected macrophages. Infect Immun 71, 3053-3057.
45. Utaisincharoen, P., Tangthawornchaikul, N., Kespichayawattana, W., Chaisuriya, P., and Sirisinha, S. (2001). Burkholderia pseudomallei interferes with inducible nitric oxide synthase (iNOS) production: a possible mechanism of evading macrophage killing. Microbiol Immunol 45, 307-313.
46. Van Zandt, K.E., Greer, M.T., and Gelhaus, H.C. (2013). Glanders: an overview of infection in humans. Orphanet J Rare Dis 8, 131.
47. Van Zandt, K.E., Tuanyok, A., Keim, P.S., Warren, R.L., and Gelhaus, H.C. (2012). An objective approach for Burkholderia pseudomallei strain selection as challenge material for medical countermeasures efficacy testing. Front Cell Infect Microbiol 2, 120.
48. Wand, M.E., Muller, C.M., Titball, R.W., and Michell, S.L. (2011). Macrophage and Galleria mellonella infection models reflect the virulence of naturally occurring isolates of B. pseudomallei, B. thailandensis and B. oklahomensis. BMC Microbiol 11, 11.
49. White, N.J. (2003). Melioidosis. Lancet 361, 1715-1722.
50. Whitlock, G.C., Estes, D.M., and Torres, A.G. (2007). Glanders: off to the races with Burkholderia mallei. FEMS Microbiol Lett 277, 115-122.
51. Wulfkuhle, J.D., Berg, D., Wolff, C., Langer, R., Tran, K., Illi, J., Espina, V., Pierobon, M., Deng, J., Demichele, A., Walch, A., Bronger, H., Becker, I., Waldhor, C., Hofler, H., Esserman, L., Liotta, L.A., Becker, K.F., and Petricoin, E.F., 3rd (2012). Molecular analysis of HER2 signaling in human breast cancer by functional protein pathway activation mapping. Clin Cancer Res 18, 6426-6435.